1. Home
  2. PTRN vs HAE Comparison

PTRN vs HAE Comparison

Compare PTRN & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PTRN

Pattern Group Inc.

HOLD

Current Price

$17.75

Market Cap

2.4B

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$56.99

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTRN
HAE
Founded
2013
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.8B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
PTRN
HAE
Price
$17.75
$56.99
Analyst Decision
Strong Buy
Buy
Analyst Count
10
9
Target Price
$19.56
$84.13
AVG Volume (30 Days)
1.1M
760.1K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.54
EPS
N/A
2.46
Revenue
N/A
$910,373,000.00
Revenue This Year
$27.89
N/A
Revenue Next Year
$22.19
$5.23
P/E Ratio
N/A
$23.23
Revenue Growth
N/A
N/A
52 Week Low
$9.19
$47.32
52 Week High
$20.10
$87.32

Technical Indicators

Market Signals
Indicator
PTRN
HAE
Relative Strength Index (RSI) 75.36 48.77
Support Level $15.81 $54.92
Resistance Level $18.95 $62.48
Average True Range (ATR) 0.92 3.09
MACD 0.23 0.20
Stochastic Oscillator 90.67 61.06

Price Performance

Historical Comparison
PTRN
HAE

About PTRN Pattern Group Inc.

Pattern Group Inc is an ecommerce accelerator, uses its technology platform, data science and a team of experts to drive growth for brands. The Company acquires inventory from brand partners to sell to consumers, enabling full control over content, pricing, logistics and customer service. Brand partners that contract with the Company operate in various industries including health and wellness, beauty and personal care, home and lifestyle, pet, sports and outdoors and consumer electronics.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: